New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free

Thursday, November 19, 2026

Back to the front page

Knife River: A Transitional Year at a Trough Multiple

Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets production, pricing and AI-led efficiency gains in 2027.

From X

Qualstar: Initiation Report

Qualstar targets 8% revenue growth in 2027 and 12% in 2028 as AI-driven storage demand and LTO-10 replacement cycles revive tape libraries.

ADCT · long

Adc Therapeutics SA (adct)

ADC Therapeutics centers on ZYNLONTA, an approved CD19-directed antibody-drug conjugate, after shares rose from roughly $4.

Why Muse May Never Need Ads

Muse could sidestep ads by becoming a neutral commerce agent, while DoorDash and Airbnb build proprietary agents that steer users toward…

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

Seeking Alpha 97 of 301

X accounts we follow

Every account on this site, hand-picked.

94 accounts

Investor letters we follow

383 firms

Sectors

Ordered by how often our editor reaches for them.